Cancer risks are elevated among relatives of MRE11A, RAD50 and NBN mutation carriers but similar to mutation negative families in a laboratory based cohort

Date:
Sunday, Oct 16, 2016 11:00am – 12:00pm
Conference:
ASHG 2016
Authors:
Dajun Qian, Holly Laduca, Hsiao-Mei Lu, Shuwei Li, Virginia Speare
Collaborators:

Genes for which cancer risks are not well characterized are included on clinical nextgeneration sequencing­based multi­gene panel tests (MGPT), including MRE11A, RAD50, and NBN (MRN).